Document
IPR2016-01665, No. 1041-41 Exhibit - 1041 Sales Path of Toviaz and Other OABs (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1041-41 Exhibit - 1041 Sales Path of Toviaz and Other OABs (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1010-10 Exhibit - 1010 Postlind Drug Metabolism and Disposition 1998 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1010-10 Exhibit - 1010 Postlind Drug Metabolism and Disposition 1998 (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1051-51 Exhibit - 1002 File History for USPN 6,858,650 Part 3 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1051-51 Exhibit - 1002 File History for USPN 6,858,650 Part 3 (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1006-6 Exhibit - 1006 Andersson Review BJU International 1999 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1006-6 Exhibit - 1006 Andersson Review BJU International 1999 (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1009-9 Exhibit - 1009 Detrol Label Pharmacia and Upjohn (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1009-9 Exhibit - 1009 Detrol Label Pharmacia and Upjohn (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1052-52 Exhibit - 1002 File History for USPN 6,858,650 Part 4 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1052-52 Exhibit - 1002 File History for USPN 6,858,650 Part 4 (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1037-37 Exhibit - 1037 US OAB Prescriptions and Shares by Drug 2008 2014 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1037-37 Exhibit - 1037 US OAB Prescriptions and Shares by Drug 2008 2014 (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1038-38 Exhibit - 1038 US OAB Sales and Shares by Drug 2008 2014 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1038-38 Exhibit - 1038 US OAB Sales and Shares by Drug 2008 2014 (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1024-24 Exhibit - 1024 Toviaz Label Pfizer Labs (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1024-24 Exhibit - 1024 Toviaz Label Pfizer Labs (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1003-3 Exhibit - 1003 Declaration of Steven E Patterson, PhD (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1003-3 Exhibit - 1003 Declaration of Steven E Patterson, PhD (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1031-31 Exhibit - 1031 Begley 1996 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1031-31 Exhibit - 1031 Begley 1996 (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1002-2 Exhibit - 1002 File History for USPN 6,858,650 Part 1 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1002-2 Exhibit - 1002 File History for USPN 6,858,650 Part 1 (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1013-13 Exhibit - 1013 Berge 1977 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1013-13 Exhibit - 1013 Berge 1977 (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1055-55 Exhibit - 1012 Bundgaard Design of Prodrugs 1985 Part 4 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1055-55 Exhibit - 1012 Bundgaard Design of Prodrugs 1985 Part 4 (P.T.A.B. Aug. 22, 2016)
+ More Snippets
Document
IPR2016-01665, No. 1025-25 Exhibit - 1025 FDA Approval Letter NDA20 771 (P.T.A.B. Aug. 22, 2016)
Cite Document
IPR2016-01665, No. 1025-25 Exhibit - 1025 FDA Approval Letter NDA20 771 (P.T.A.B. Aug. 22, 2016)
+ More Snippets